How early utilisation of AI can de-riskand accelerate clinical development
outsourcing-pharma.com Recent investments by major pharmaceutical companies signal a growing confidence inartificial intelligence's(AI's) potential to transform drug …
outsourcing-pharma.com 2
Covers: HealthcareChatbots & LLMsCopyright & IPBias & Fairness
Interview: Mike Connell, CEO at Enthought on the trials and tribulations of AI
outsourcing-pharma.com Two primary generative AI risksto be aware of involve intellectual property (IP) and bias. Safeguarding your IP—your R&D data—from being used to …